Clinical Trials
5 trialsNCT05797168 2026-06-03
FONTANA
AstraZeneca
Phase 1/2 Recruiting
NCT04485013 2026-02-18
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
Phase 1 Recruiting
NCT04339218 2026-01-30
CRYOMUNE
Institut Bergonié
Phase 3 Recruiting
NCT05887492 2025-11-18
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
Tango Therapeutics, Inc.
Phase 1/2 Recruiting
NCT05266846 2024-05-30
BEYOND
Hunan Province Tumor Hospital
Phase 2 Recruiting